Abstract
The family Zygophyllaceae has almost 22 genera and more than 250 species. Fagonia is an important genus of the family Zygophyllaceae. This genus comprises abundant species, which grows in different phytogeographical regions of the world. These species grow in different environmental conditions. Fagonia indica belongs to Zygophyllaceae. It is commonly known as Dhamasa, Dhamana, Sachi booti and Shoka’a and is found in deserts of Asia and Africa. The species of this family are of very high importance. This article is a review based on different studies regarding occurrence, phytochemistry, traditional uses, biochemical constituents and therapeutic uses of F. indica. The available literature review provided a base for this review. The presence of flavonoids, saponins, tannins, glycosides, pectin and alkaloids was confirmed by different researchers. F. indica is a very important medicinal plant because it has different therapeutic and traditional uses such as antidiabetic, anticancer, anti leishmanial, antipyretic, anti-inflammatory, laxative, gastroprotective, hepatoprotective and antioxidant effects. Further in vitro and in vivo studies should be carried out to find the exact mechanisms of actions for better scientific evidence.
Keywords: Fagonia indica, phytochemistry, traditional uses, pharmacological profile, therapeutic potential, future prospects, Nutritious value.
Current Pharmaceutical Design
Title:Fagonia indica; A Review on Chemical Constituents, Traditional Uses and Pharmacological Activities
Volume: 27 Issue: 22
Author(s): Kashif Ali and Haroon Khan*
Affiliation:
- Department of Pharmacy, Abdul Wali Khan University Mardan, Mardan 23200,Pakistan
Keywords: Fagonia indica, phytochemistry, traditional uses, pharmacological profile, therapeutic potential, future prospects, Nutritious value.
Abstract: The family Zygophyllaceae has almost 22 genera and more than 250 species. Fagonia is an important genus of the family Zygophyllaceae. This genus comprises abundant species, which grows in different phytogeographical regions of the world. These species grow in different environmental conditions. Fagonia indica belongs to Zygophyllaceae. It is commonly known as Dhamasa, Dhamana, Sachi booti and Shoka’a and is found in deserts of Asia and Africa. The species of this family are of very high importance. This article is a review based on different studies regarding occurrence, phytochemistry, traditional uses, biochemical constituents and therapeutic uses of F. indica. The available literature review provided a base for this review. The presence of flavonoids, saponins, tannins, glycosides, pectin and alkaloids was confirmed by different researchers. F. indica is a very important medicinal plant because it has different therapeutic and traditional uses such as antidiabetic, anticancer, anti leishmanial, antipyretic, anti-inflammatory, laxative, gastroprotective, hepatoprotective and antioxidant effects. Further in vitro and in vivo studies should be carried out to find the exact mechanisms of actions for better scientific evidence.
Export Options
About this article
Cite this article as:
Ali Kashif and Khan Haroon *, Fagonia indica; A Review on Chemical Constituents, Traditional Uses and Pharmacological Activities, Current Pharmaceutical Design 2021; 27 (22) . https://dx.doi.org/10.2174/1381612826666201210105941
DOI https://dx.doi.org/10.2174/1381612826666201210105941 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Vascular Disrupting Agents (VDAs) in Anticancer Therapy
Current Clinical Pharmacology Gastrin-Releasing Peptide Receptor Targeting in Cancer Treatment: Emerging Signaling Networks and Therapeutic Applications
Current Drug Targets Arene ruthenium(II) Complexes: The Promising Chemotherapeutic Agent in Inhibiting the Proliferation, Migration and Invasion
Mini-Reviews in Medicinal Chemistry MicroRNAs in the Pathobiology of Multiple Myeloma
Current Cancer Drug Targets Imaging Localised Hydrogen Peroxide Production in Living Systems
Current Chemical Biology Recent Advances in Sepsis Research: Novel Biomarkers and Therapeutic Targets
Current Medicinal Chemistry CAM Use in Pediatric Oncology
Current Pediatric Reviews Discovery of Hedgehog Antagonists for Cancer Therapy
Current Medicinal Chemistry Identification and Characterization of BRCA1 and BRCA2 Founder Mutations
Current Women`s Health Reviews Efficient Gene Selection for Cancer Prognostic Biomarkers Using Swarm Optimization and Survival Analysis
Current Bioinformatics Adiponectin: A Key Player in Obesity Related Disorders
Current Pharmaceutical Design Fibroblast Growth Factors in Development and Cancer: Insights from the Mammary and Prostate Glands
Current Drug Targets Systemic Sclerosis: Clinical Manifestations
Current Rheumatology Reviews Design and Discovery of Novel Quinoxaline Derivatives as Dual DNA Intercalators and Topoisomerase II Inhibitors
Anti-Cancer Agents in Medicinal Chemistry Synthesis and Evaluation of A New Series of Thiazole Derivatives as Potential Antitumor Agents and MMP Inhibitors
Anti-Cancer Agents in Medicinal Chemistry Undermining Tumor Angiogenesis by Gene Therapy: An Emerging Field
Current Gene Therapy Identification of Key mRNAs, miRNAs, and mRNA-miRNA Network Involved in Papillary Thyroid Carcinoma
Current Bioinformatics Inhibition of Transcription Factors by Plant-Derived Compounds and their Implications in Inflammation and Cancer
Current Pharmaceutical Design Power from the Garden: Plant Compounds as Inhibitors of the Hallmarks of Cancer
Current Medicinal Chemistry The Real Impact of Target Therapy in Breast Cancer Patients: Between Hope and Reality
Current Cancer Drug Targets